(K1) Specialty Pharmaceuticals in Development

Wednesday, October 16, 2024

8:30 AM – 9:45 AM PT

Location: Boulevard Ballroom

ACPE UAN:0233-0000-24-053-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Yuqian Liu, PharmD

Senior Director, Specialty Clinical Solutions
Prime Therapeutics
Richmond, TX
Soumya Vishwanath, PharmD

Sr. Manager, Formulary Management
Prime Therapeutics
Arlington, MA

Moderator(s)

Annie Schuster, PharmD, FAMCP

Senior Director, Clinical Pharmacy Programs
The Cigna Group

In recent years, specialty pharmaceuticals have surged ahead of traditional drug approvals – and the momentum shows no signs of slowing. What does this mean for the future of health care and managed care pharmacy? Join us to explore how these cutting-edge treatments are reshaping the industry and what it means for managed care professionals.

This session dives into recent drug spend trends for specialty medications and spotlights newly approved and emerging therapies. The session will also discuss the potential impact of these cutting-edge treatments to help managed care professionals navigate this evolving landscape.

Learning Objectives:

At the completion of this activity, participants should be able to:

Identify recently approved specialty medications and those that are likely to be approved in the next 12 months.
Describe the mechanism of action, indications, efficacy, and safety of new and emerging specialty medications.
Describe the likely impact of new specialty medications on the managed care market.